248 related articles for article (PubMed ID: 26965518)
21. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
22. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
23. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
24. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract][Full Text] [Related]
25. The administration of L-thyroxine as soft gel capsule or liquid solution.
Vita R; Fallahi P; Antonelli A; Benvenga S
Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
[TBL] [Abstract][Full Text] [Related]
26. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
[TBL] [Abstract][Full Text] [Related]
27. Treatment of congenital hypothyroidism: comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age.
Vigone MC; Ortolano R; Vincenzi G; Pozzi C; Ratti M; Assirelli V; Vissani S; Cavarzere P; Mussa A; Gastaldi R; Di Mase R; Salerno M; Street ME; Trombatore J; Weber G; Cassio A
Eur J Endocrinol; 2021 Nov; 186(1):45-52. PubMed ID: 34714772
[TBL] [Abstract][Full Text] [Related]
28. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.
Hoermann R; Midgley JE; Giacobino A; Eckl WA; Wahl HG; Dietrich JW; Larisch R
Clin Endocrinol (Oxf); 2014 Dec; 81(6):907-15. PubMed ID: 24953754
[TBL] [Abstract][Full Text] [Related]
29. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
Peterson ME; Melián C; Nichols R
J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
[TBL] [Abstract][Full Text] [Related]
30. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.
Peroni E; Vigone MC; Mora S; Bassi LA; Pozzi C; Passoni A; Weber G
Horm Res Paediatr; 2014; 81(1):50-4. PubMed ID: 24247169
[TBL] [Abstract][Full Text] [Related]
31. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
32. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.
Sato T; Suzuki Y; Taketani T; Ishiguro K; Nakajima H
J Clin Endocrinol Metab; 1977 Mar; 44(3):553-9. PubMed ID: 402383
[TBL] [Abstract][Full Text] [Related]
33. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
34. Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study.
Fallahi P; Ferrari SM; Materazzi G; Ragusa F; Ruffilli I; Patrizio A; Miccoli P; Antonelli A
Laryngoscope Investig Otolaryngol; 2018 Oct; 3(5):405-408. PubMed ID: 30410995
[TBL] [Abstract][Full Text] [Related]
35. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
Sato T; Ishiguro K; Suzuki Y; Taketani T; Isumisawa A
J Clin Endocrinol Metab; 1976 Feb; 42(2):385-90. PubMed ID: 816807
[TBL] [Abstract][Full Text] [Related]
36. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF.
Busnelli A; Vannucchi G; Paffoni A; Faulisi S; Fugazzola L; Fedele L; Somigliana E
Eur J Endocrinol; 2015 Oct; 173(4):417-24. PubMed ID: 26139211
[TBL] [Abstract][Full Text] [Related]
37. [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].
Ann Med Interne (Paris); 1983; 134(7):636-42. PubMed ID: 6666901
[TBL] [Abstract][Full Text] [Related]
38. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
39. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism.
Tzifi F; Iliadi A; Voutetakis A; Platis D; Girginoudis P; Kanaka-Gantenbein C
J Pediatr Endocrinol Metab; 2022 Feb; 35(2):239-247. PubMed ID: 34653328
[TBL] [Abstract][Full Text] [Related]
40. l-Thyroxine in an Oral Liquid or Softgel Formulation Ensures More Normal Serum Levels of Free T4 in Patients with Central Hypothyroidism.
Benvenga S; Capodicasa G; Perelli S
Front Endocrinol (Lausanne); 2017; 8():321. PubMed ID: 29209276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
